Semaglutide Clinics in Iowa
Compare Semaglutide providers in Iowa. Check ratings, telehealth availability, and insurance acceptance to find the right prescriber.
Cities With Semaglutide Providers in Iowa
All Semaglutide Clinics in Iowa
Mantality Health Des Moines, Iowa
Limitless Male Medical Clinic
Weight Loss in Des Moines
Gameday Men's Health West Des Moines
WellForm MD
4Ever Young Med Spa & Wellness Center
Allure Rx Aesthetics & Medical Weight Loss
Revive Dermatology Clinic and Spa
New Leaf Wellness
Five One Five Wellness and Aesthetics
Coachlight Clinic & Spa
Yost Wellness Center
Innovate My Weight and Wellness
Aesthetic Collective
Sono Bello Des Moines
Corva Medical
Vela Wellness Clinic
Kalen & Co. Aesthetics
Optima Medical Weight Loss & Wellness Center
VitalUty Wellness
Nourish Med Spa
Renew Vitality Testosterone Clinic of Cedar Rapids
Iowa Wellness Center
Gameday Men's Health North Liberty TRT Clinic
Cosmetic Solutions Laser and Skin Care Center
Holistic Wellness & Psychiatry
Limitless Male Medical Clinic
Integrative Health and Hormone Clinic
About Semaglutide in Iowa
What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, which regulates appetite and blood sugar. Originally developed for type 2 diabetes (Ozempic), it was later approved at a higher dose for chronic weight management (Wegovy). Semaglutide has become the most recognized name in the GLP-1 weight loss category, with clinical trials showing average weight loss of 15-17% of body weight.
Brand Names
Semaglutide is available as Ozempic, Wegovy, Rybelsus, manufactured by Novo Nordisk.
Expected Weight Loss
In the STEP 1 trial, participants on Wegovy 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo. About one-third of participants lost 20% or more of their body weight.
Cost in Iowa
Without insurance, Semaglutide typically costs $800-$1,200/month (Ozempic), $1,300-$1,400/month (Wegovy). With insurance, costs range from $25-$200/month (varies by plan). Compounded options may be available at $200-$500/month.
Savings programs: Novo Nordisk offers savings cards for eligible commercially insured patients. NovoCare patient assistance program available for uninsured/underinsured patients.
Frequently Asked Questions
There are 30 clinics prescribing Semaglutide (Ozempic and Wegovy and Rybelsus) in Iowa. Iowa is one of the better-served states for Semaglutide availability.
Yes, 22 of 30 Semaglutide providers in Iowa (73%) offer telehealth. Most providers here support virtual visits, so you can start treatment without an office visit.
Brand-name Ozempic and Wegovy and Rybelsus costs $800–$1,400/month without insurance in Iowa. Compounded Semaglutide from clinic weight loss programs typically runs $200–$500/month. With insurance, copays range from $25–$200/month depending on your plan's formulary and whether prior authorization is required.
Yes. Semaglutide is a prescription medication in all US states including Iowa. You can get evaluated and prescribed through 22 telehealth providers in Iowa, or visit any of the 30 clinics listed here in person.
Coverage depends on your plan and diagnosis. Semaglutide is widely covered for type 2 diabetes. For weight management, coverage is expanding — Wegovy and Zepbound now have broader approval, but many plans still require prior authorization or documented BMI criteria. Check with your insurer or ask the clinic to verify coverage before your appointment.
Related Articles
Ozempic vs Wegovy: What's the Difference?
Both contain semaglutide, but they're FDA-approved for different purposes. Here's what you need to know before choosing between them.
newsFDA Warning Letter to Novo Nordisk: What Ozempic and Wegovy Patients Should Know
The FDA issued a warning letter to Novo Nordisk over unreported potential side effects. Here is what it actually means for patients taking Ozempic or Wegovy.
weight-lossSemaglutide Weight Loss Results: What to Expect Month by Month
A realistic timeline of semaglutide weight loss results based on clinical trials and real-world data — from the first week through month 12 and beyond.